SEATTLE, WASHINGTON, UNITED STATES, October 19, 2023 /EINPresswire.com/ -- Coherent Market Insights has come up with a new market research report titled “Smart Insulin Pen Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030″. The report covers share, size, and forecast by top players, regions, applications, and product types, and forecast from 2023 to 2030, along with historic data. The Smart Insulin Pen Market study covers in-depth insights on the competitive scenario, description, wide product portfolio of key vendors, SWOT analysis, massive business strategy adopted by competitors, revenue, Porter’s Five Forces Analysis, and sales estimates. The report’s primary objective is to supply a further illustration of the newest scenario, economic slowdown, and War situations impact on the overall industry and exhaustive scope to cover all the possible segments helping every stakeholder in the Smart Insulin Pen market.

Request FREE Sample Report @
https://www.coherentmarketinsights.com/insight/request-sample/3436

Recent Development of Smart Insulin Pen market:

✤In June 2021, Novo Nordisk Pharma, a U.S. based healthcare company, announced that it had obtained Japanese regulatory approval from Pharmaceuticals and Medical Devices Agency for NovoPen 6 and NovoPen Echo Plus as medical devices, the first smart insulin pens to be approved in the country.

✤In May 2021, Eli Lilly and Company, a U.S. based pharmaceutical company, announced that it had signed strategic international agreements with four companies – DexCom, Inc., U.S. based manufacturer of glucose monitoring system, Glooko Inc.,U.S. based software company for diabetes mobile applications, myDiabby Healthcare, France based medical software company and Roche, a Switzerland-based pharmaceutical company – to advance connected solutions and streamline care for people living with diabetes in markets outside of the U.S.

✤In November 2022, Novo Nordisk, a Denmark based pharmaceutical company, announced that its smart insulin pens can now be connected to the Abbott FreeStyle LibreLink app.

✤In March 2022, Glooko Inc., a U.S. based provider of remote patient monitoring and data management solutions for diabetes and other chronic diseases, announced the acquisition of DIABNEXT. DIABNEXT is a France-based company offers a telemedicine platform that helps diabetic patients better manage their disease and stay in touch remotely with the health professionals who follow them to improve the balance of their diabetes. The DIABNEXT mobile application completes Glooko's product portfolio.

Competitive Landscape With Key Players

List of Top Key Players in Smart Insulin Pen Market Report are: Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk, Companion Medical Inc., Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Pendiq GmbH, Sanofi, Berlin Chemie Companion Medical Inc., Bigfoot Biomedical, Digital Medics Pty ltd, Eli Lilly and company, Ypsomed Holding AG, Diabnext Diamesco Co. Ltd.

Regional Analysis:

➸ North America (United States, Canada and Mexico)

➸ Europe (Germany, UK, France, Italy, Russia and Turkey, Rest of Europe)

➸ Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam Rest of Asia)

➸ South America (Brazil, Argentina, Columbia, Reset of South America)

➸ Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and Rest of South Africa & Middle East)

Direct Purchase This Premium Report & Get Up To 25 % Off @
https://www.coherentmarketinsights.com/insight/buy-now/3436

Segment Analysis

Smart Insulin Pen Market is segmented as

✎By Indication: Type 1 Diabetes, Type 2 Diabetes
✎By Connectivity : Bluetooth, USB
✎By Distribution Channel: Clinics and Ambulatory Surgical Centers, e-Commerce, Retail Pharmacies
Why Choose Quince Market Insights?

☛ Authentic Method: To ensure high-level data integrity, accurate analysis, and impeccable forecasts

☛ Analyst Support: For complete satisfaction of our customers

☛ Targeted Market View: Targeted market view to provide pertinent information and save time of readers

☛ Agile Approach: A faster and efficient way to cater to the needs with continuous iteration

☛ Customization: Customization of the report’s scope as needed to meet your requirements

Frequently asked questions:

What are the major growth drivers and market trends that impacts Smart Insulin Pen market?
What is the market size both in terms of value and volume for the Smart Insulin Pen market?
Who are the leading market players and who are the new market players that operates in the market with an estimated market share?
What are the future investment pockets and opportunities in the global Smart Insulin Pen market?

Request Customized Report @
https://www.coherentmarketinsights.com/insight/request-customization/3436

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.